Leucid Bio Employee Directory
Biotechnology ResearchEngland, United Kingdom11-50 Employees
Leucid Bio is a London-based biotechnology company focused on advancing CAR-T cell therapies for refractory cancers. It aims to deliver stronger and more durable anti-tumor responses than earlier CAR-T generations through its proprietary Lateral CAR platform. The company is pursuing a gene therapy program, including LEU011, and works with partners to support development and manufacturing. Strategic collaborations include Lonza’s Cocoon platform for phase I manufacturing and a quality-assurance partnership with GOSH at the Zayed Centre for Research into Rare Disease in Children. The company has engaged with ImaginAb in a joint effort, and it participates in industry events, including the Morgan Stanley Global Healthcare Conference in New York in 2025.